KRAS and familial pancreatic carcinoma: We further identified and described a G4mid-selective small molecule, NSC 317605, and demonstrated the synergistic activities with enhanced selectivity for the KRAS promoter G4mid, improved transcriptional downregulation and correlating effects on KRAS-dependent AsPc-1 pancreatic cancer cells.